Abstract
Alzheimer's disease (AD) is a common chronic and destructive disease. The early diagnosis of AD is difficult, thus the need for clinically applicable biomarkers development is growing rapidly. There are many methods to biomarker discovery and identification. In this review, we aim to summarize Mass spectrometry (MS)-based proteomics studies on AD and discuss thoroughly the methods to identify candidate biomarkers in cerebrospinal fluid (CSF) and blood. This review will also discuss the potential research areas on biomarkers.
| Original language | English |
|---|---|
| Pages (from-to) | 7865-7882 |
| Number of pages | 18 |
| Journal | International Journal of Molecular Sciences |
| Volume | 15 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 6 May 2014 |
Keywords
- Alzheimer's disease
- Biomarker
- Mass spectrometry
- Proteomics
Fingerprint
Dive into the research topics of 'Biomarkers in Alzheimer's disease analysis by mass spectrometry-based proteomics'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver